Toxocara canis: Difference between revisions

(Created page with "==Background== ==Clinical Features== *Visceral toxocariasis (visceral larva migrans) **Larvae travel through liver / lungs / CNS causing fever, cough, enlarged liver, pneumon...")
 
(Text replacement - "OR" to "'''OR'''")
 
(5 intermediate revisions by 3 users not shown)
Line 12: Line 12:


==Management==
==Management==
*Diethylcarbamazine 6mg/kg/day divided TID x 7-10 days '''OR''' mebendazole 100-200mg BID x 5 days '''OR''' albendazole 400mg BID  x 3-5 days


==Disposition==
==Disposition==
Line 22: Line 23:
==External Links==
==External Links==


==Sources==
==References==
<references/>
<references/>


[[Category:ID]]
[[Category:ID]]
[[Category:TropMed]]
[[Category:Tropical Medicine]]

Latest revision as of 22:51, 30 May 2017

Background

Clinical Features

  • Visceral toxocariasis (visceral larva migrans)
    • Larvae travel through liver / lungs / CNS causing fever, cough, enlarged liver, pneumonia
  • Ocular toxocariasis (ocular larva migrans)
    • Larvae travel to the eye causing inflammation and scarring of retina, usually only one eye, irreversible vision loss

Differential Diagnosis

Workup

Management

  • Diethylcarbamazine 6mg/kg/day divided TID x 7-10 days OR mebendazole 100-200mg BID x 5 days OR albendazole 400mg BID x 3-5 days

Disposition

See Also

External Links

References